← All trials
NCT01468064
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 1, 2011
- Primary completion
- Mar 1, 2017
- Completion date
- Mar 1, 2017
- First posted
- —
- Last posted
- —
- Enrollment
- 20
- Arms / groups
- 3 / —
- Source
- AACT · pre-existing
Sponsors
- Southern Medical UniversityLead sponsor
- Cellonis Biotechnology Co. Ltd.Collaborator
- Southern Medical UniversityOverall official - principal investigator
- Guangzhou Medical UniversityCollaborator
- Second People's Hospital of Nanhai District of FoshanCollaborator
- Southern Medical UniversityReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.